Memantine and Donepezil Hydrochlorides Extended-release (Amneal Pharmaceuticals LLC)


Welcome to the PulseAid listing for the Memantine and Donepezil Hydrochlorides Extended-release drug offered from Amneal Pharmaceuticals LLC. This NMDA Receptor Antagonists [MoA],N-methyl-D-aspartate Receptor Antagonist [EPC],Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Amneal Pharmaceuticals LLC
NON-PROPRIETARY NAME: Memantine and Donepezil
SUBSTANCE NAME: MEMANTINE HYDROCHLORIDE; DONEPEZIL HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: NMDA Receptor Antagonists [MoA],N-methyl-D-aspartate Receptor Antagonist [EPC],Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, EXTENDED RELEASE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-02-01
END MARKETING DATE: 0000-00-00


Memantine and Donepezil Hydrochlorides Extended-release HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMemantine and Donepezil Hydrochlorides Extended-release from Amneal Pharmaceuticals LLC
LABELER NAME: Amneal Pharmaceuticals LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 28; 10(mg/1; mg/1)
START MARKETING DATE: 2017-02-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69238-1247_ad61d86b-04dc-4d86-9eee-ce1b453a22b8
PRODUCT NDC: 69238-1247
APPLICATION NUMBER: ANDA208328

Other MEMANTINE HYDROCHLORIDE; DONEPEZIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Allergan, Inc.Namzaric
Amneal Pharmaceuticals LLCMemantine and Donepezil Hydrochlorides Extended-release